Rules - 2009

DRUG SCHEDULING ACTIONS

• Proposed Rule - Placement of Carisoprodol Into Schedule IV (November 17, 2009)
• Proposed Rule - Placement of 5-Methoxy-N,N- Dimethyltryptamine Into Schedule I of the Controlled Substances Act (October 28, 2009)
• Placement of Fospropofol Into Schedule IV (October 6, 2009)
• Proposed Rule - Placement of 5-Methoxy-N,N- Dimethyltryptamine Into Schedule I
  (August 21, 2009)
• Proposed Rule - Placement of Fospropofol Into Schedule IV (July 23, 2009)
• Placement of Tapentadol Into Schedule II (May 21, 2009)
• Placement of Lacosamide into Schedule V (May 21, 2009)
• Proposed Rule - Schedules of Controlled Substances: Placement of Lacosamide into
  Schedule V (March 10, 2009)
• Proposed Rule - Schedules of Controlled Substances: Placement of Tapentadol Into Schedule II (February 17, 2009)

ANABOLIC STEROIDS

• Classification of Three Steroids as Schedule III Anabolic Steroids Under the Controlled Substances Act (December 4, 2009)

REGISTRATION

• Registration Requirements for Individual Practitioners Operating in a "Locum Tenens" Capacity (October 28, 2009)

GENERAL

• Identification of Institution-based Individual Practitioners (September 9, 2009)
• Schedules of Controlled Substances; Table of Excluded Nonnarcotic Products: Nasal Decongestant Inhalers Manufactured by Classic Pharmaceuticals LLC (August 28, 2009)
• Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act of 2008
  (April 6, 2009)
• Disposal of Controlled Substances by Persons Not Registered With the Drug Enforcement Administration (January 21, 2009)

NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO).